NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation
Antioxidants · 06.10.2023 · 12 (10) · 1833
DOI: 10.3390/antiox12101833 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 06.10.2023. Verfasst von Roberto Ramos-Mondragón und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Michigan, 1150 West Medical Center Drive, 2301 Medical Science Research Building III, Ann Arbor, MI 48109, …. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 292 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Michigan Medicine-PKUHSC Joint Institute for Translational and Clinical Research Discovery, University of Michigan Frankel Cardiovascular Center 2022 Inaugural award.
Abstract (Originalsprache)
Atrial fibrillation (AF) is the most common type of cardiac arrhythmia and its prevalence increases with age. The irregular and rapid contraction of the atria can lead to ineffective blood pumping, local blood stasis, blood clots, ischemic stroke, and heart failure. NADPH oxidases (NOX) and mitochondria are the main sources of reactive oxygen species in the heart, and dysregulated activation of NOX and mitochondrial dysfunction are associated with AF pathogenesis. NOX- and mitochondria-derived oxidative stress contribute to the onset of paroxysmal AF by inducing electrophysiological changes in atrial myocytes and structural remodeling in the atria. Because high atrial activity causes cardiac myocytes to expend extremely high energy to maintain excitation-contraction coupling during persistent AF, mitochondria, the primary energy source, undergo metabolic stress, affecting their morphology, Ca2+ handling, and ATP generation. In this review, we discuss the role of oxidative stress in activating AF-triggered activities, regulating intracellular Ca2+ handling, and functional and anatomical reentry mechanisms, all of which are associated with AF initiation, perpetuation, and progression. Changes in the extracellular matrix, inflammation, ion channel expression and function, myofibril structure, and mitochondrial function occur during the early transitional stages of AF, opening a window of opportunity to target NOX and mitochondria-derived oxidative stress using isoform-specific NOX inhibitors and mitochondrial ROS scavengers, as well as drugs that improve mitochondrial dynamics and metabolism to treat persistent AF and its transition to permanent AF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, University of Michigan, 1150 West Medical Center Drive, 2301 Medical Science Research Building III, Ann Arbor, MI 48109, USA.
- Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI 48019, USA.
- Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.
ORCID-Profile: Andrey Lozhkin, Nageswara R Madamanchi
Förderung
- NHLBI NIH HHS
- Michigan Medicine-PKUHSC Joint Institute for Translational and Clinical Research Discovery
- University of Michigan Frankel Cardiovascular Center 2022 Inaugural award
- University of Michigan Frankel Cardiovascular Center C. Steve Baum Stem Cell Research Award
- NIH
Zitieren
APA
Ramos-Mondragón, R., Lozhkin, A., Vendrov, A. E., Runge, M. S., Isom, L. L., & Madamanchi, N. R. (2023). NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation. Antioxidants, 12(10), 1833. https://doi.org/10.3390/antiox12101833
Vancouver
Ramos-Mondragón R, Lozhkin A, Vendrov AE, Runge MS, Isom LL, Madamanchi NR. NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation. Antioxidants. 2023;12(10):1833. doi:10.3390/antiox12101833
BibTeX
@article{RamosMondragn2023,
author = {Ramos-Mondragón, Roberto and Lozhkin, Andrey and Vendrov, Aleksandr E and Runge, Marschall S and Isom, Lori L and Madamanchi, Nageswara R},
title = {NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {10},
pages = {1833},
doi = {10.3390/antiox12101833}
}
EUVIMED